Pfizer Irinotecan Hydrochloride Injectable

Pfizer Irinotecan Hydrochloride Injectable is a trusted and effective chemotherapy solution used primarily to treat metastatic colorectal cancer. As a topoisomerase I inhibitor, it works by interfering with the DNA replication process in cancer cells, preventing their growth and proliferation.

This high-quality injectable is manufactured by Pfizer, a renowned leader in the pharmaceutical industry, ensuring safety and efficacy. Irinotecan Hydrochloride is frequently used in combination with other medications to enhance treatment outcomes, making it a critical component of cancer management protocols.

• Topoisomerase I Inhibitor: Effectively disrupts cancer cell DNA replication.
• High Efficacy: Proven to be effective in managing colorectal cancer in advanced stages.
• Combination Use: Works well with other chemotherapy agents to optimize cancer treatment.
• Sterile and Safe Packaging: Ensures contamination-free administration in clinical settings.
• Trusted Manufacturer: Developed and manufactured by Pfizer, a global leader in pharmaceuticals.
• Precise Dosage Control: Allows healthcare professionals to administer accurate dosages.
• Multi-Dose Vial: Convenient packaging for multiple uses during treatment regimens.
• Clinical Compatibility: Compatible with a range of IV solutions and other chemotherapeutic agents.
• Patient-Centric Care: Plays a key role in improving survival rates in cancer patients.
• Reliable Cancer Treatment: A preferred choice among oncologists for advanced cancer care.

• Colorectal Cancer Treatment: Effective in managing advanced or metastatic colorectal cancer.
• Combination Therapy: Commonly used with other chemotherapy drugs like 5-fluorouracil and leucovorin.
• Tumor Growth Prevention: Inhibits the DNA replication process in cancer cells to limit tumor growth.
• Other Cancers: Occasionally prescribed for other types of cancers as deemed appropriate by oncologists.

Q. What is Pfizer Irinotecan Hydrochloride Injectable used for?
A. It is used primarily to treat metastatic colorectal cancer and may also be prescribed for other cancers based on medical advice.

Q. How is Irinotecan Hydrochloride administered?
A. It is administered intravenously (IV) by a healthcare professional in a clinical setting.

Q. Can this medication be used in combination with other drugs?
A. Yes, it is often used with other chemotherapy agents like 5-fluorouracil and leucovorin for better treatment outcomes.

Q. What are the possible side effects of this medication?
A. Common side effects include nausea, vomiting, diarrhea, fatigue, and hair loss. Severe side effects should be reported to a healthcare provider immediately.

Q. Who should not take this medication?
A. Patients with known allergies to Irinotecan Hydrochloride or those with certain liver and blood disorders should avoid this medication.

Q. How should Pfizer Irinotecan Hydrochloride Injectable be stored?
A. Store it at room temperature, protected from light, and keep it out of reach of children.

Q. Is this medication suitable for pediatric use?
A. The use of this medication in children should only be considered under strict medical supervision.

Q. Can pregnant or breastfeeding women use this medication?
A. It is generally not recommended for use during pregnancy or breastfeeding. Consult a healthcare professional for guidance.

Q. What should I do if I miss a dose?
A. Contact your healthcare provider for instructions if you miss a scheduled dose.

Q. Can I continue my normal activities during treatment?
A. You may need to adjust your activities based on how your body responds to the treatment. Always consult your doctor for personalized advice.